This study was conducted to assess the efficacy of OM-85 BV (Broncho-Vaxom) in the prevention of pediatric recurrent respiratory tract infections (RTIs). Available evidence suggests that defining recurrent RTIs as <or=3 infections per fall-winter semester is both medically and epidemiologically justified. Therefore, this criterion was chosen as a primary endpoint
In order to evaluate the efficacy of macrolides in pediatric patients with recurrent respiratory tra...
In order to evaluate the efficacy of macrolides in pediatric patients with recurrent respiratory tra...
In healthy infants and young children, the development of respiratory tract infections (RTIs) is ext...
Background: This study was conducted to assess the efficacy of OM-85 BV (Broncho-Vaxom) in the preve...
In otherwise healthy infants and young children, respiratory tract infections (RTIs) are extremely c...
The burden of respiratory tract infections in paediatrics is extremely high, in both industrialised ...
In otherwise healthy infants and young children, respiratory tract infections (RTIs) are extremely c...
Recurrent respiratory tract infections (RRTIs) are very common in children and a major challenge for...
Recurrent infections of upper and lower respiratory tract have an important clinical and economic im...
Preschool children frequently suffer from acute respiratory tract infections (ARTI). Immunostimulant...
Preschool children frequently suffer from acute respiratory tract infections (ARTI). Immunostimulant...
Background: In Italy, the bacterial lysate OM-85 (Broncho-Vaxom®, Broncho-Munal®, Ommunal®, Paxoral®...
Background: In Italy, the bacterial lysate OM-85 (Broncho-Vaxom®, Broncho-Munal®, Ommunal®, Paxoral®...
BACKGROUND: Recurrent acute respiratory tract infections (ARTI) are a common problem in childhood. S...
Efficacy of over-the-counter immunostimulants in the prevention of paediatric recurrent acute respir...
In order to evaluate the efficacy of macrolides in pediatric patients with recurrent respiratory tra...
In order to evaluate the efficacy of macrolides in pediatric patients with recurrent respiratory tra...
In healthy infants and young children, the development of respiratory tract infections (RTIs) is ext...
Background: This study was conducted to assess the efficacy of OM-85 BV (Broncho-Vaxom) in the preve...
In otherwise healthy infants and young children, respiratory tract infections (RTIs) are extremely c...
The burden of respiratory tract infections in paediatrics is extremely high, in both industrialised ...
In otherwise healthy infants and young children, respiratory tract infections (RTIs) are extremely c...
Recurrent respiratory tract infections (RRTIs) are very common in children and a major challenge for...
Recurrent infections of upper and lower respiratory tract have an important clinical and economic im...
Preschool children frequently suffer from acute respiratory tract infections (ARTI). Immunostimulant...
Preschool children frequently suffer from acute respiratory tract infections (ARTI). Immunostimulant...
Background: In Italy, the bacterial lysate OM-85 (Broncho-Vaxom®, Broncho-Munal®, Ommunal®, Paxoral®...
Background: In Italy, the bacterial lysate OM-85 (Broncho-Vaxom®, Broncho-Munal®, Ommunal®, Paxoral®...
BACKGROUND: Recurrent acute respiratory tract infections (ARTI) are a common problem in childhood. S...
Efficacy of over-the-counter immunostimulants in the prevention of paediatric recurrent acute respir...
In order to evaluate the efficacy of macrolides in pediatric patients with recurrent respiratory tra...
In order to evaluate the efficacy of macrolides in pediatric patients with recurrent respiratory tra...
In healthy infants and young children, the development of respiratory tract infections (RTIs) is ext...